Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosamprenavir for Laryngopharyngeal Reflux
NCT04383262Phase 2Recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosamprenavir in laryngopharyngeal reflux (LPR), sponsored by Medical College of Wisconsin. Started Oct 2026; status: recruiting.
02
Drugs
fosamprenavir
03
Conditions
laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on NCT04383262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04383262.